NCT06778824View on ClinicalTrials.gov

Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.

NARecruitingINTERVENTIONAL
Enrollment

610

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Gut-Brain DisordersGERD Without Erosive Esophagitis
Interventions
DRUG

Takepron

Participants are expected to take a proton-pump inhibitor (PPI) for 12 weeks, with a dosage of 30 mg taken once a day.

DRUG

Zoloft 50Mg Tablet

Participants are expected to take a selective serotonin reuptake inhibitor (SSRI) for 12 weeks, with a dosage of 50 mg taken once a day.

DRUG

Imipramine Pill

Participants are expected to take tricyclic antidepressants (TCA) for 12 weeks, with a dosage of 25 mg taken twice a day.

Trial Locations (1)

970

RECRUITING

Hualien Tzu Chi Hospital,Buddhist Tzu Chi Medical Foundation, Hualien City

All Listed Sponsors
lead

Hualien Tzu Chi General Hospital

OTHER